Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Grou...

por Biesaga, Beata, Niemiec, Joanna, Ziobro, Marek
Publicado 2012

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

por Biesaga, Beata, Niemiec, Joanna, Ziobro, Marek
Publicado en J Cancer Res Clin Oncol (2014)

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors

por Kamińska-Winciorek, Grażyna, Cybulska-Stopa, Bozena, Lugowska, Iwona, Ziobro, Marek, Rutkowski, Piotr
Publicado en Postepy Dermatol Alergol (2019)

Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer

por Cybulska-Stopa, Bożena, Ziobro, Marek, Skoczek, Marta, Kojs-Pasińska, Ewelina, Cedrych, Ida, Brandys, Anna
Publicado 2013

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV

por Cybulska-Stopa, Bożena, Skoczek, Marta, Ziobro, Marek, Świtaj, Tomasz, Falkowski, Sławomir, Morysiński, Tadeusz, Hetnał, Marcin, Cedrych, Ida, Rutkowski, Piotr
Publicado 2013

Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer

por Niemiec, Joanna A, Adamczyk, Agnieszka, Ambicka, Aleksandra, Mucha-Małecka, Anna, Wysocki, Wojciech M, Biesaga, Beata, Ziobro, Marek, Cedrych, Ida, Grela-Wojewoda, Aleksandra, Domagała-Haduch, Małgorzata, Wysocka, Joanna, Ryś, Janusz, Sas-Korczyńska, Beata
Publicado en Am J Transl Res (2017)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study

por Cybulska-Stopa, Bożena, Ługowska, Iwona, Jagodzińska-Mucha, Paulina, Koseła-Paterczyk, Hanna, Kozak, Katarzyna, Klimczak, Anna, Świtaj, Tomasz, Ziobro, Marek, Roman, Agnieszka, Rajczykowski, Marcin, Suwiński, Rafał, Niemiec, Maciej, Zemełka, Tomasz, Falkowski, Sławomir, Rutkowski, Piotr
Publicado en Postepy Dermatol Alergol (2019)

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma

por McDermott, David F., Lee, Jae-Lyun, Ziobro, Marek, Suarez, Cristina, Langiewicz, Przemyslaw, Matveev, Vsevolod Borisovich, Wiechno, Pawel, Gafanov, Rustem Airatovich, Tomczak, Piotr, Pouliot, Frederic, Donskov, Frede, Alekseev, Boris Yakovlevich, Shin, Sang Joon, Bjarnason, Georg A., Castellano, Daniel, Silverman, Rachel Kloss, Perini, Rodolfo F., Schloss, Charles, Atkins, Michael B.
Publicado en J Clin Oncol (2021)